The dean's request seemed to Guan Yuntian to be completely unnecessary, but other leaders of Jianhua Medical Research Institute who participated in the negotiations regarded it as an imperial edict. They believed that this was the tone set by the dean for this negotiation.

Sure enough, in the negotiation on the second day, Vice President Feng, who was in charge of scientific research, and Director Peng of the External Cooperation Office were highly consistent in their views. However, Guan Yuntian was also prepared for this, "Last night at the wine table,

, the dean mentioned the issue of the shares of both parties in the cooperation project. We reiterate that Changda Group respects the work of scientific researchers and should let the results of small experiments reflect its value and will not care too much about this matter.

.”

"In this case, Mr. Guan believes that Jianhua Pharmaceutical Research Institute, based on its small-scale trial results, should occupy a large share of the industrialized trial projects cooperated by both parties."

"This matter, what I say doesn't count, and what you say doesn't count, because no one knows how valuable your small test results are. Do you know how much this result is worth?" Guan Yuntian said.

.

Lao Peng glanced at Vice President Feng, and then said: "It's not that there is nothing. We know the approximate value of this achievement."

"Oh, Director Peng, tell me, how much is your achievement worth?"

Lao Peng actually reported a figure, but Guan Yuntian was noncommittal, "I wonder if the price reported by Director Peng was a casual estimate by you? Or was it estimated by some other agency? What is the basis for the estimate?"

"This is our estimate, and there is no basis for it, but Jianhua Pharmaceutical Research Institute has its own set of experiences."

Guan Yuntian shook his head, "Although we are interested in this achievement and are willing to respect the work of the relevant scientific and technological personnel, with all due respect, first of all, the objectivity of your own estimated value of the achievement is questionable; in addition, you do not have any

Based on the results estimated based on experience, I think it is not enough to be used as a bargaining chip in cooperative projects."

"But you can't deny the value of the results, right?" Director Peng was also straightforward.

"I will never deny the value of scientific research results at any time. The question is, how much is it worth? A fair evaluation by a neutral institution is needed to be convincing." Guan Yuntian said.

"Evaluation from a neutral institution----, I'm afraid it's difficult to handle. Where can I find such an institution?" Vice President Feng interjected.

The reception room fell into a brief silence, and Guan Yuntian didn't know where such an institution existed. At this time, Dr. Tong interjected: "As far as I know, in megacities such as Beijing and Shanghai and several larger provincial capital cities, in the past few years,

Intangible assets appraisal agencies appeared in 2008, but they involve highly professional projects, and the appraisal fees are slightly higher."

"It's certainly good to have such an organization, but before making an assessment, should the two sides continue to discuss the next step of cooperation?" Lao Peng said.

"Of course the negotiations must continue. Just put aside the equity ratios of both parties in the cooperation for the time being." Guan Yuntian said.

"Yes, we can continue to discuss other cooperation details. However, the intangible assets evaluation fee is relatively high. What should we do with the evaluation fee?" This is also a matter of detail. Vice President Feng raised it on the spot, which is completely understandable.

"If Jianhua Medical Research Institute can trust us, the money can be paid by Changda Group." Guan Yuntian is always very generous whenever he encounters this kind of situation.

"Well... I think it's best for both parties to come forward at the same time to avoid unnecessary suspicion." Director Peng felt that Jianhua Medical Research Institute was not short of the money.

"It's best to find an intermediary agency with a good reputation. Both parties can come forward at the same time and try to be fair and transparent." Although the other party rejected his generosity, Guan Yuntian believed that the credibility of the assessment should be guaranteed.

The discussion on that day not only reached an intention to cooperate, but also preliminarily agreed on the specific details. Dr. Tong also recommended several intangible asset evaluation agencies for the other party's reference. Both parties agreed that after the value evaluation of the pilot results is completed, the formal intangible assets evaluation agency will be officially established in Changda Group.

Sign a cooperation agreement.

Perhaps he had doubts about the appraisal agency recommended by Dr. Tong. After Guan Yuntian and his party left, according to the instructions of the hospital leaders, Director Peng began to look for intangible assets appraisal agencies. After multiple consultations, he discovered that the intermediary agency recommended by Dr. Tong was in

It was the most credible institution in the country, but its fees were also high. In order to save money, Lao Peng found two institutions that were not well-known and had lower fees.

Director Peng informed Guan Yuntian of the situation on the phone, and Guan Yuntian said without hesitation: "For the sake of fairness and transparency, of course we should let the most credible agency evaluate it."

Lao Peng secretly complained that at that time Guan Yuntian had voluntarily agreed that Changda Group would bear the evaluation fee. Perhaps in order to defend the dignity of Jianhua Pharmaceutical Research Institute or to prevent Changda Group from manipulating the evaluation process, he decisively rejected Guan Yuntian's generosity.

.

Now not only does the evaluation have to be done by the institution with the highest fees, but the cost has to be borne by Jianhua Pharmaceutical Research Institute alone. The advantage of door-to-door delivery has not been taken advantage of, and an evaluation fee has to be paid. Lao Peng regretted it to his guts. The key is

He couldn't justify himself in front of the hospital leaders. In fact, he couldn't blame others for this, because Lao Peng thought too much from the beginning!

In any case, this is the plan chosen by Lao Peng. Even if he is reluctant, he must continue to move forward in accordance with the agreement between the two parties. Jianhua Pharmaceutical Research Institute provided the necessary information to the intermediary agency selected by both parties, and the other party provided it within a week.

After the evaluation report came out, Guan Yuntian learned the news and immediately invited the relevant leaders of Jianhua Pharmaceutical Research Institute to go to Changda Group to sign a cooperation agreement, and asked YHM project leader Shi Gong to go with him.

Three days later, several leaders and engineers from Jianhua Pharmaceutical Research Institute who participated in the last discussion arrived at Changda Group. On the first day, General Manager Ye Jiayi took the guests to visit the production bases of the branches of Changda Group and the northern mountainous area.

agricultural projects, and finally visited the technology center. The guests fully felt the strong strength of Changda Group.

The business negotiations that started the next day included not only formulating the details of the first negotiation into written terms, but also the other main content was to confirm the shareholding proportions of both parties in the joint development of the industrialized pilot project.

Director Peng showed the evaluation report given by the intermediary agency. The value of the pilot results of the YHM project of Jianhua Pharmaceutical Research Institute was clearly marked in the evaluation report. Guan Yuntian and others had no objections to the valuation of the authoritative agency.

Subsequently, Ye Jiayi presented the investment estimate for the YHM industrialization pilot project and handed the estimate to the guests opposite, asking them to read it one by one.

Vice President Feng, Lao Peng and others were a little surprised after reading the relevant contents of the investment budget. They subjectively believed that Jianhua Pharmaceutical Research Institute would definitely invest in the industrialized pilot project jointly produced by YHM based on the value of its pilot results.

If you can hold a large share, you will know after looking at the investment details that the value of YHM’s pilot results accounts for up to 40% of the entire cooperation project.

"It turns out that the investment budget includes not only production equipment and testing instruments, but also workshop buildings, storage facilities and construction land?" It seems that Lao Peng has objections to this.

"Of course these aspects must be included. As we all know, a project requires not only production equipment and testing instruments, but also factory buildings, warehouses and land. Otherwise, where will the equipment and instruments be installed? How will the project be implemented? We are here in a development zone.

The land prices are clearly marked and well documented," Ye Jiayi said.

"Actually, there are still some investments that we have not included, such as the construction of water, electricity and other public projects, as well as dealing with local environmental protection and security inspection departments. These are all required

Capital investment." Guan Yuntian said.

Lao Peng felt that what the other party said was reasonable. If all investments were included, the equity share of Jianhua Pharmaceutical Research Institute would only be about 30%. He exchanged glances with Vice President Feng, and Lao Feng motioned for him to see him.

Okay, just accept it.

After the cooperation agreement was successfully signed, the leaders of Jianhua Pharmaceutical Research Institute decided to return to their unit the next day. In the afternoon, they decided to set up a project implementation leadership group to interface with Changda Group. The group leader was Vice President Feng.

Lao Peng from the department serves as the deputy team leader, and YHM project leader Shi Gong and several of his assistants are team members. Shi Gong is the specific leader of Jianhua Pharmaceutical Research Institute during the project implementation.

In order to save time, before the guests left, Guan Yuntian suggested that Shi Gong stay for a few more days to communicate with the technical department of Changda Group and negotiate the next work plan.

Although Jianhua Pharmaceutical Research Institute has a working group in name, in fact, during the project implementation process, the main people who dealt with Changda Group were Shi Gong and his scientific research team, especially this Shi Gong, who was in the pilot stage of the YHM project.

As the person in charge, technical issues can only be handled by him with the relevant departments of Changda Group. Therefore, Guan Yuntian's request was legitimate and reasonable, and Shi Gong stayed on legitimately.

The next morning, after sending off Vice President Feng and his party, Guan Yuntian had a small-scale conversation with Shi Shi in his office. After individual contact, he found that this scientific and technical personnel named Shi Xiaodong was indeed introverted and did not talk much.

, he looked a little embarrassed when he first entered the office. No wonder he had worked at Jianhua Medical Research Institute for more than ten years, but except for the completed YHM trial, he had no other influential achievements.

Through conversation, I learned that Shi Xiaodong is not a local. His hometown is a small county in another province. His wife is a local and works in a local company. He has a child who is in the fourth grade of elementary school. His parents are retired employees from his hometown. Shi Xiaodong himself

He is also an only child.

At this stage, Guan Yuntian feels that knowing this information is enough.

Shi Xiaodong was somewhat flattered to be invited to the chairman's office alone to chat with family. After all, in Jianhua Medical Research Institute, not to mention the president and vice president, even the department directors of the agency did not have anyone like him who had no connections and no connections.

He has a low background, doesn't know how to make connections, and only does practical work. However, the chairman of such a large Changda Group has no airs, is approachable, and gives people a sense of intimacy.

Shi Xiaodong did not expect that the first time he was chatting alone with an unfamiliar leader from another unit, he would change from being cautious at first to becoming more and more relaxed. Perhaps affected by his emotions, he would talk more and more.

When they met alone for the first time, Guan Yuntian didn't want to touch on other topics except for family affairs. Unexpectedly, Shi Xiaodong took the initiative and asked: "Mr. Guan, the business of Changda Group involves many sectors. It seems that pharmaceutical products are an emerging industry among them. I don't know.

What position does this business have in the company?”

The other party’s question was more serious, so Guan Yuntian certainly had to take it seriously, “Yes, Changda Group has only been involved in the pharmaceutical sector for four or five years, but we want to expand this business, which is why we actively seek project cooperation with external parties.

As an expert in the industry, what do historians think about the prospects of the pharmaceutical industry?"

"I don't dare to be an expert, just a practitioner. My point is that with the development of science and technology today, it is easy for human beings to go to the sky, go to the earth, and dive into the sea. However, no one can fully eat grains and live on the earth.

Avoid getting sick. Some people say that many diseases do not require treatment at all and can be cured by relying on human immunity. I think this view is too extreme. There is no need for injections and medicine for a mild cold. What if it is a serious cold? Or the person's immunity is not enough.

How strong is it? In the end, we have to rely on medical treatment to solve the problem."
Chapter completed!